Predictors of early re-bleeding and mortality after acute variceal haemorrhage in patients with cirrhosis

Bambha, K.; Kim, W. A.; Pedersen, A.; Bida, J. P.; Kremers, W. K.; Kamath, P. S.
June 2008
Gut;Jun2008, Vol. 57 Issue 6, p814
Academic Journal
Background and aims: Risk factors for mortality and re- bleeding following acute variceal haemorrhage (AVH) are incompletely understood. The aim of this study was to determine risk factors for 6-week mortality, and re-bleeding within 5 days in patients with cirrhosis and AVH. Methods: Kaplan-Meier and Cox proportional hazards regression analyses were used to determine risk factors among 256 patients with AVH entered into a randomised, prospective trial. Results: Thirty-five patients (14%) died within 6 weeks of AVH; 14 depths (40%) occurred within 5 days. Only the Model for End-stage Liver Disease (MELD) score and units of packed red blood cells (PRBCs) transfused in the first 24 h were associated with 6-week mortality univariately (HR 1.11 p<0.001; HR 1.22, p<0.001) and bivariately (HR MELD = 1.10, p<0.001; HR per unit of PRBCs transfused = 1.15, p = 0.005). Re-bleeding within 5 days occurred in 37 patients (15%); MELD score (p = 0.01) and a clot on a varix (p = 0.05) predicted re-bleeding. Patients with a MELD score ⩾18; both MELD score ⩾`18 and ⩾4 units of PRBCs transfused; both MELD score ⩾18 and active bleeding at index endoscopy; and variceal re-bleeding had increased risk of death 6 weeks post-AVH (HR = 7.4, p<0.001; 11.3, p<0.001; 9.9, p<0.001; 10.2, p<0.001 respectively). Conclusions: Patients with AVH and MELD score ⩾18, requiring ⩾4 units of PRBCs within the first 24 h or with active bleeding at endoscopy are at increased risk of dying within 6 weeks. MELD score ⩾18 is also a strong predictor of variceal re-bleeding within the first 5 days.


Related Articles

  • Bleeding time in patients with hepatic cirrhosis. Blake, J.C.; Sprengers, D.; Grech, P.; McCormick, P.A.; McIntyre, N.; Burroughs, A.K. // BMJ: British Medical Journal (International Edition);7/1/90, Vol. 301 Issue 6742, p12 

    Determines the frequency of an abnormal bleeding time in patients with cirrhosis in Great Britain. Factors affecting primary hemostasis and to the severity of liver disease; Existence of a correlation between the bleeding time and the platelet count; Appropriateness of the measurement of...

  • Direct Oral Anticoagulants in Cirrhosis Patients Pose Similar Risks of Bleeding When Compared to Traditional Anticoagulation. Intagliata, N.; Henry, Z.; Maitland, H.; Shah, N.; Argo, C.; Northup, P.; Caldwell, S. // Digestive Diseases & Sciences;Jun2016, Vol. 61 Issue 6, p1721 

    Background and Aims: Direct oral anticoagulants (DOAC) are important new anticoagulant therapies that are not well studied in patients with chronic liver disease. The aim of this study was to compare rates of bleeding in cirrhosis patients treated with DOAC (factor Xa inhibitors:...

  • Should We Use the Model for End-Stage Liver Disease (MELD) to Predict Mortality After Colorectal Surgery? Pantel, Haddon; Stensland, Kristian; Nelson, Jason; Francone, Todd; Roberts, Patricia; Marcello, Peter; Read, Thomas; Ricciardi, Rocco; Pantel, Haddon Jacob; Stensland, Kristian D; Francone, Todd D; Roberts, Patricia L; Marcello, Peter W // Journal of Gastrointestinal Surgery;Aug2016, Vol. 20 Issue 8, p1511 

    We sought to determine the accuracy of the Model for End-Stage Liver Disease and the Mayo Clinic Postoperative Mortality Risk in Patients with Cirrhosis Calculator in patients with ascites who underwent colorectal surgery. The National Surgical Quality Improvement Program database was queried...

  • Bleeding gastric varices: stick to the sticky glue . Karnam, Umaprasanna S.; O’Loughlin, Colm J.; Reddy, K. Rajender // American Journal of Gastroenterology;Jan2002, Vol. 97 Issue 1, p199 

    In this prospective seminal study from Taiwan 74 cirrhotic patients with histories of gastric variceal bleeding were randomized to two groups. The group receiving endoscopic variceal obturation with butyl cyanoacrylate (GVO) comprised 31 patients, and the group receiving pneumatic-driven...

  • Hassab's operation for bleeding gastric varices. Mitsis, Michael; Katsanos, Konstantinos H.; Fatouros, Michael; Tsianos, Epameinondas V. // Annals of Gastroenterology;Apr2012, Vol. 25 Issue 2, p182 

    A letter to the editor is presented about the case of a 67-year-old patient with alcoholic cirrhosis who was diagnosed with bleeding esophageal grade II varices and gastric varices.

  • Impairment of psychomotor responses after conscious sedation in cirrhotic patients undergoing therapeutic upper GI endoscopy. Vasudevan, A.E.; Goh, K.L.; Bulgiba, A.M. // American Journal of Gastroenterology;Jul2002, Vol. 97 Issue 7, p1717 

    OBJECTIVES:The aim of this study was to determine whether the number connection test (NCT) times of a group of cirrhotic patients without clinically overt hepatic encephalopathy and a group of healthy patients without liver disease who were undergoing endoscopy were prolonged after sedation with...

  • Laparoscopic cholecystectomy in cirrhotic patients: the value of MELD score and Child–Pugh classification in predicting outcome. Delis, Spiros; Bakoyiannis, Andreas; Madariaga, Juan; Bramis, John; Tassopoulos, Nikos; Dervenis, Christos // Surgical Endoscopy;Feb2010, Vol. 24 Issue 2, p407 

    Laparoscopic cholecystectomy is a challenging procedure in patients with cirrhosis. This study aims to evaluate the safety and outcome of laparoscopic cholecystectomy in patients with cirrhosis and examines the value of model for end-stage liver disease (MELD) score and Child–Pugh...

  • Primary Prevention of Variceal Bleeding: Pharmacological Therapy Versus Endoscopic Banding. Karadsheh, Zeid; Allison, Harmony // North American Journal of Medical Sciences;Oct2013, Vol. 5 Issue 10, p573 

    \Variceal bleeding is one of the most feared complications in patients with liver cirrhosis. It continues to be a leading cause of death among patients with liver cirrhosis. Although its prognosis has improved over the last several decades, it still carries substantial mortality. Preventing...

  • Editorial: Beta-Blockers and the Prevention of Decompensation in Cirrhosis: Worth the Trouble. Northup, Patrick G; Henry, Zachary H // American Journal of Gastroenterology;Mar2012, Vol. 107 Issue 3, p428 

    Non-selective beta-blockers have been a cornerstone of therapy for prevention of esophageal variceal bleeding in cirrhosis patients for more than two decades. When lowering the hepatic vein portal pressure gradient (HVPG) below 12 mm Hg or decreasing the pressure by 20% from baseline, these...


Read the Article


Sign out of this library

Other Topics